PMC:7212965 / 47717-47912
Annnotations
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T132","span":{"begin":64,"end":75},"obj":"Chemical"},{"id":"T133","span":{"begin":80,"end":90},"obj":"Chemical"}],"attributes":[{"id":"A132","pred":"chebi_id","subj":"T132","obj":"http://purl.obolibrary.org/obo/CHEBI_134722"},{"id":"A133","pred":"chebi_id","subj":"T133","obj":"http://purl.obolibrary.org/obo/CHEBI_145994"}],"text":"In particular, Gl adverse events are poorly understood for both favipiravir and remdesivir, including the frequency and severity of aminotransferase elevations and incidence of Gl manifestations."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T319","span":{"begin":0,"end":195},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In particular, Gl adverse events are poorly understood for both favipiravir and remdesivir, including the frequency and severity of aminotransferase elevations and incidence of Gl manifestations."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"1286","span":{"begin":64,"end":75},"obj":"Chemical"},{"id":"1287","span":{"begin":80,"end":90},"obj":"Chemical"}],"attributes":[{"id":"A1286","pred":"tao:has_database_id","subj":"1286","obj":"MESH:C462182"},{"id":"A1287","pred":"tao:has_database_id","subj":"1287","obj":"MESH:C000606551"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In particular, Gl adverse events are poorly understood for both favipiravir and remdesivir, including the frequency and severity of aminotransferase elevations and incidence of Gl manifestations."}